Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide

C. McDermott, R. Chess-Williams, K. A. Mills, S. H. Kang, S. E. Farr, G. D. Grant, A. V. Perkins, A. K. Davey, S. Anoopkumar-Dukie

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

Abstract

The effects of pseudomonal virulence factor pyocyanin, and LPS from Pseudomonas aeruginosa and Escherichia coli on urothelial mediator release and cytokine production were examined. RT4 urothelial cells were treated with pyocyanin (1-100μM) or LPS (1-100ng/mL) for 24-h. Effects were measured in terms of changes in cell viability, basal and stretch-induced acetylcholine (Ach) and PGE2 release, and inflammatory cytokines (IL-6 and IL-12) production. Twenty-four hour pyocyanin (100μM) treatment significantly decreased urothelial cell viability, while stretch-induced Ach release response was inhibited. E. coli LPS (100ng/mL) produced a similar response with an additional significant increase in basal Ach release. All three virulence factors significantly increased urothelial PGE2 release; under basal release for pyocyanin (100μM), stretch-induced release for pseudomonal LPS (≥10ng/mL) and both basal and stimulated release for E. coli LPS (≥10ng/mL). IL-6 and IL-12 were not detected in control samples, however 24h treatment with pyocyanin (100μM) or LPS (100ng/mL) resulted in IL-6 release from urothelial cells. The changes in urothelial Ach and PGE2, and release of inflammatory cytokine IL-6 induced by exposure to the bacterial virulence factors may play a role in the symptoms of pain and urinary urgency experienced with urinary tract infections.

Original languageEnglish
Pages (from-to)1693-1698
Number of pages6
JournalToxicology in Vitro
Volume27
Issue number6
DOIs
Publication statusPublished - Sep 2013

Fingerprint

Pyocyanine
Dinoprostone
Acetylcholine
Lipopolysaccharides
Interleukin-6
Virulence Factors
Escherichia coli
Interleukin-12
Cytokines
Cell Survival
Cells
Therapeutics
Urinary Tract Infections
Pseudomonas aeruginosa
Pain

Cite this

McDermott, C. ; Chess-Williams, R. ; Mills, K. A. ; Kang, S. H. ; Farr, S. E. ; Grant, G. D. ; Perkins, A. V. ; Davey, A. K. ; Anoopkumar-Dukie, S. / Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide. In: Toxicology in Vitro. 2013 ; Vol. 27, No. 6. pp. 1693-1698.
@article{f1220472ac074070b83f276f0e2e1cd9,
title = "Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide",
abstract = "The effects of pseudomonal virulence factor pyocyanin, and LPS from Pseudomonas aeruginosa and Escherichia coli on urothelial mediator release and cytokine production were examined. RT4 urothelial cells were treated with pyocyanin (1-100μM) or LPS (1-100ng/mL) for 24-h. Effects were measured in terms of changes in cell viability, basal and stretch-induced acetylcholine (Ach) and PGE2 release, and inflammatory cytokines (IL-6 and IL-12) production. Twenty-four hour pyocyanin (100μM) treatment significantly decreased urothelial cell viability, while stretch-induced Ach release response was inhibited. E. coli LPS (100ng/mL) produced a similar response with an additional significant increase in basal Ach release. All three virulence factors significantly increased urothelial PGE2 release; under basal release for pyocyanin (100μM), stretch-induced release for pseudomonal LPS (≥10ng/mL) and both basal and stimulated release for E. coli LPS (≥10ng/mL). IL-6 and IL-12 were not detected in control samples, however 24h treatment with pyocyanin (100μM) or LPS (100ng/mL) resulted in IL-6 release from urothelial cells. The changes in urothelial Ach and PGE2, and release of inflammatory cytokine IL-6 induced by exposure to the bacterial virulence factors may play a role in the symptoms of pain and urinary urgency experienced with urinary tract infections.",
author = "C. McDermott and R. Chess-Williams and Mills, {K. A.} and Kang, {S. H.} and Farr, {S. E.} and Grant, {G. D.} and Perkins, {A. V.} and Davey, {A. K.} and S. Anoopkumar-Dukie",
year = "2013",
month = "9",
doi = "10.1016/j.tiv.2013.04.015",
language = "English",
volume = "27",
pages = "1693--1698",
journal = "Toxicology in Vitro",
issn = "0887-2333",
publisher = "Elsevier",
number = "6",

}

Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide. / McDermott, C.; Chess-Williams, R.; Mills, K. A.; Kang, S. H.; Farr, S. E.; Grant, G. D.; Perkins, A. V.; Davey, A. K.; Anoopkumar-Dukie, S.

In: Toxicology in Vitro, Vol. 27, No. 6, 09.2013, p. 1693-1698.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Alterations in acetylcholine, PGE2 and IL6 release from urothelial cells following treatment with pyocyanin and lipopolysaccharide

AU - McDermott, C.

AU - Chess-Williams, R.

AU - Mills, K. A.

AU - Kang, S. H.

AU - Farr, S. E.

AU - Grant, G. D.

AU - Perkins, A. V.

AU - Davey, A. K.

AU - Anoopkumar-Dukie, S.

PY - 2013/9

Y1 - 2013/9

N2 - The effects of pseudomonal virulence factor pyocyanin, and LPS from Pseudomonas aeruginosa and Escherichia coli on urothelial mediator release and cytokine production were examined. RT4 urothelial cells were treated with pyocyanin (1-100μM) or LPS (1-100ng/mL) for 24-h. Effects were measured in terms of changes in cell viability, basal and stretch-induced acetylcholine (Ach) and PGE2 release, and inflammatory cytokines (IL-6 and IL-12) production. Twenty-four hour pyocyanin (100μM) treatment significantly decreased urothelial cell viability, while stretch-induced Ach release response was inhibited. E. coli LPS (100ng/mL) produced a similar response with an additional significant increase in basal Ach release. All three virulence factors significantly increased urothelial PGE2 release; under basal release for pyocyanin (100μM), stretch-induced release for pseudomonal LPS (≥10ng/mL) and both basal and stimulated release for E. coli LPS (≥10ng/mL). IL-6 and IL-12 were not detected in control samples, however 24h treatment with pyocyanin (100μM) or LPS (100ng/mL) resulted in IL-6 release from urothelial cells. The changes in urothelial Ach and PGE2, and release of inflammatory cytokine IL-6 induced by exposure to the bacterial virulence factors may play a role in the symptoms of pain and urinary urgency experienced with urinary tract infections.

AB - The effects of pseudomonal virulence factor pyocyanin, and LPS from Pseudomonas aeruginosa and Escherichia coli on urothelial mediator release and cytokine production were examined. RT4 urothelial cells were treated with pyocyanin (1-100μM) or LPS (1-100ng/mL) for 24-h. Effects were measured in terms of changes in cell viability, basal and stretch-induced acetylcholine (Ach) and PGE2 release, and inflammatory cytokines (IL-6 and IL-12) production. Twenty-four hour pyocyanin (100μM) treatment significantly decreased urothelial cell viability, while stretch-induced Ach release response was inhibited. E. coli LPS (100ng/mL) produced a similar response with an additional significant increase in basal Ach release. All three virulence factors significantly increased urothelial PGE2 release; under basal release for pyocyanin (100μM), stretch-induced release for pseudomonal LPS (≥10ng/mL) and both basal and stimulated release for E. coli LPS (≥10ng/mL). IL-6 and IL-12 were not detected in control samples, however 24h treatment with pyocyanin (100μM) or LPS (100ng/mL) resulted in IL-6 release from urothelial cells. The changes in urothelial Ach and PGE2, and release of inflammatory cytokine IL-6 induced by exposure to the bacterial virulence factors may play a role in the symptoms of pain and urinary urgency experienced with urinary tract infections.

UR - http://www.scopus.com/inward/record.url?scp=84878376123&partnerID=8YFLogxK

U2 - 10.1016/j.tiv.2013.04.015

DO - 10.1016/j.tiv.2013.04.015

M3 - Article

VL - 27

SP - 1693

EP - 1698

JO - Toxicology in Vitro

JF - Toxicology in Vitro

SN - 0887-2333

IS - 6

ER -